Caixin Global – Latest China News & Headlines

Home >


CX Tech is Caixin Global's real-time tech news portal, featuring 24-hour news, short-form analysis, and roundups from business and tech media in China.

Trending in China: Did Sichuan Forget to Tell Chongqing About Their Joint Olympic Bid?
Alibaba’s Healthcare Unit Finds Tonic for Profits
Trending in China: Beijing Tackles Parking Shortage With Shared Spaces
Chinese Wireless Telecoms Operators Join Forces to Build 5G Base Stations to Reduce Costs
Ruhnn, Another U.S.-Listed Chinese Company Looks to Go Private
Unicorns surge to 500 in number as US and China account for 70%
Trending in China: Social Media Comes Out in Support of High Quality Fakes
Xiaomi-Backed IoT-Enabled Appliance Maker Sees Revenues Grow While Profits Slump
Chinese Startup WeRide Reports Promising Robotaxi Results
Trending in China: God recalls his hand – tributes to Maradona from Chinese social media after his death
Tesla to Manufacture Electric Car Chargers in China
China Restricts Livestreaming Spending and Blocks Underage Users from Tipping Performers
TikTok Granted One-Week Extension of Forced-Sale Deadline
Chinese Online Language Educator 51Talk Speaks the Language of Profit
Trending in China: Are Elderly ‘Collateral Damage’ in Increasing Technological Cashless World?
Trending in China: Black and White ‘Little Miracle’ Born to 22-Year-Old Panda in Washington
Facing U.S. Sanctions, Huawei May See Global Smartphone Share Slump to 4% in 2021
Chinese LGBTQ Dating App Owner BlueCity Acquires Youth-Focused Gay Platform Finka
Xiaomi-Backed Smart Wearables Maker Huami Sees Profits Slump Despite Revenue Growth
Baidu Maps Illegally Using Other Chinese Firm’s Mapping Info, Court Finds.
Company Dismisses Own Swine Fever Vaccine Claim as ‘Typo’

By Chen Shuning and Zhao Runhua / Jun 18, 2019 07:04 PM / Business & Tech

Photo: VCG

Photo: VCG

A Chinese pharmaceutical company has called its previous claim to be working on an African swine fever vaccine the result of a “typo” — after China’s agricultural ministry dismissed the “vaccine” as having “no scientific basis.”

The drama began last week, when Shenzhen-listed Guangdong Highsun Group said it was working with researchers to develop a vaccine that the company said could effectively “prevent and cure” the disease, which has ravaged China’s pork industry.

But the Ministry of Agriculture and Rural Affairs responded to Highsun’s claims with skepticism, saying the research team had failed to file applications for clinical trials of the alleged vaccine, and that there was no evidence to believe Highsun’s proposed solution would work.

On Monday, Highsun said an employee had made a “typo” when calling the drug a “vaccine” in an official announcement, and said it would like to “sincerely apologize” to any investors it had misled.

The clarification comes after the Shenzhen Stock Exchange asked Highsun to explain its research into the “vaccine,” after Highsun’s initial announcement caused its stock to surge for several days.

Related: Agriculture Ministry Rejects Claimed Swine Fever Vaccine Fix

Share this article
Open WeChat and scan the QR code